The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.

By J. Januzzi, C. Camargo, S. Anwaruddin, A. Baggish, A. Chen, D. Krauser, R. Tung, R. Cameron, J. Nagurney, C. Chae and 6 more. American Journal of Cardiology, 2005

1,226 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Emergency Medicine

View Paper: https://www.semanticscholar.org/paper/984321c332bca28ffdf68797639712d0d160eb59

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. M. Gheorghiade
2. M. Flemmer
3. P. Marik
4. G. Fonarow
5. J. Cleland
6. Gerasimos Filippatos
7. E. Braunwald
8. S. Anker

Citations in the corpus

• State of the art: Using natriuretic peptide levels in clinical practice (2008, methodology): “, ADVIA Centaur, ShionoRIA BNP assay in US (central lab) and Roche Elecys 2004 BASEL trial showing reduction in morbidity and treatment cost with BNP published [16] 2005 Beckman central lab (Biosite antibody) and Abbott Diagnostics, AxSYM BNP assay (central lab) becomes available 2005 PRIDE study on”
• Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome* (2006, methodology): “Ethylenediamine-tetraacetic–acid plasma was obtained from 99 subjects with acute cardiogenic pulmonary edema drawn from patients enrolled in 2003 in a study of N-terminal pro– brain-natriuretic-peptide for the diagnosis of acute destabilized heart failure in patients with acute dyspnea (16).”
• Heart failure with preserved ejection fraction. (2006, methodology): “Therefore, it has been used to distinguish a normal from a “pseudonormal” LV filling pattern((15)).”
• Narrative Review (2012, background): “In the ‘‘Pro-BNP Investigation of Dyspnea in the Emergency Department (PRIDE)’’ study, the best diagnostic threshold was 900 pg/mL, with a level less than 300 pg/mL being optimal for ruling out HF.(25) The measurement of B-type natriuretic peptides on presentation to the ED has been demonstrated to ”